Counterpoint Mutual Funds LLC Purchases Shares of 321,757 Aveanna Healthcare Holdings Inc. $AVAH

Counterpoint Mutual Funds LLC acquired a new position in shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 321,757 shares of the company’s stock, valued at approximately $2,854,000. Aveanna Healthcare accounts for about 0.2% of Counterpoint Mutual Funds LLC’s holdings, making the stock its 20th biggest position. Counterpoint Mutual Funds LLC owned about 0.15% of Aveanna Healthcare as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently modified their holdings of the stock. EverSource Wealth Advisors LLC grew its holdings in Aveanna Healthcare by 88,100.0% in the third quarter. EverSource Wealth Advisors LLC now owns 11,466 shares of the company’s stock worth $102,000 after purchasing an additional 11,453 shares during the period. Hillsdale Investment Management Inc. acquired a new position in shares of Aveanna Healthcare during the third quarter valued at about $7,922,000. Lion Street Advisors LLC bought a new position in shares of Aveanna Healthcare during the 3rd quarter worth about $89,000. Vanguard Group Inc. grew its stake in shares of Aveanna Healthcare by 34.7% in the 3rd quarter. Vanguard Group Inc. now owns 4,041,659 shares of the company’s stock valued at $35,850,000 after buying an additional 1,041,324 shares during the period. Finally, JPMorgan Chase & Co. increased its position in Aveanna Healthcare by 32.4% in the 3rd quarter. JPMorgan Chase & Co. now owns 209,491 shares of the company’s stock valued at $1,858,000 after buying an additional 51,226 shares in the last quarter. Institutional investors and hedge funds own 87.96% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on AVAH. William Blair started coverage on Aveanna Healthcare in a report on Monday, December 8th. They issued an “outperform” rating on the stock. Jefferies Financial Group increased their target price on Aveanna Healthcare from $11.00 to $12.50 and gave the stock a “buy” rating in a report on Tuesday, October 28th. UBS Group lifted their price target on shares of Aveanna Healthcare from $9.50 to $10.00 and gave the company a “neutral” rating in a research report on Thursday, January 15th. Weiss Ratings restated a “hold (c+)” rating on shares of Aveanna Healthcare in a report on Monday, December 29th. Finally, Barclays lifted their price objective on shares of Aveanna Healthcare from $9.00 to $11.00 and gave the company an “overweight” rating in a report on Friday, January 16th. Five research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Aveanna Healthcare presently has a consensus rating of “Hold” and a consensus target price of $11.06.

Aveanna Healthcare Trading Down 1.9%

Shares of AVAH stock opened at $7.20 on Tuesday. Aveanna Healthcare Holdings Inc. has a 12-month low of $3.67 and a 12-month high of $10.32. The company has a quick ratio of 1.23, a current ratio of 1.23 and a debt-to-equity ratio of 140.39. The company has a 50 day moving average of $8.42 and a 200-day moving average of $8.54. The firm has a market cap of $1.50 billion, a P/E ratio of 20.00 and a beta of 2.06.

Insider Transactions at Aveanna Healthcare

In other news, CFO Matthew Buckhalter sold 13,512 shares of the company’s stock in a transaction on Thursday, February 19th. The stock was sold at an average price of $7.21, for a total transaction of $97,421.52. Following the transaction, the chief financial officer owned 529,243 shares of the company’s stock, valued at $3,815,842.03. This represents a 2.49% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Edwin C. Reisz sold 60,769 shares of Aveanna Healthcare stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $7.21, for a total value of $438,144.49. Following the completion of the sale, the insider directly owned 1,447,057 shares of the company’s stock, valued at approximately $10,433,280.97. This trade represents a 4.03% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 998,595 shares of company stock valued at $7,567,770. 7.00% of the stock is currently owned by insiders.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.